Drug recall · April 17, 2013
Cefdinir for Oral Suspension recall
Why: Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cefdinir for Oral Suspension, 125 mg/5 mL, packaged in a) 60 mL bottle (NDC 0093-4136-64); b) 100 mL bottle (NDC 0093-4136-73), Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960.
- Lots / codes
a) Lot #: 30304253A, Exp 12/13; b) Lot #: 30304144A, Exp 12/13 and 30304477A, Exp 03/14
- Quantity
- 62,187 bottles
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Nationwide
- Initiated
- February 26, 2013 · Voluntary: Firm initiated
- Classified
- April 10, 2013
- Reported
- April 17, 2013
- Ended
- January 15, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefdinir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.